Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
POETIC was an open-label, multicentre, parallel-group, randomized, phase 3 trial done in 130 UK hospitals. Postmenopausal women aged at least 50 years...